Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-03

AUTHORS

Anirudh Prahallad, Chong Sun, Sidong Huang, Federica Di Nicolantonio, Ramon Salazar, Davide Zecchin, Roderick L. Beijersbergen, Alberto Bardelli, René Bernards

ABSTRACT

Inhibition of the BRAF(V600E) oncoprotein by the small-molecule drug PLX4032 (vemurafenib) is highly effective in the treatment of melanoma. However, colon cancer patients harbouring the same BRAF(V600E) oncogenic lesion have poor prognosis and show only a very limited response to this drug. To investigate the cause of the limited therapeutic effect of PLX4032 in BRAF(V600E) mutant colon tumours, here we performed an RNA-interference-based genetic screen in human cells to search for kinases whose knockdown synergizes with BRAF(V600E) inhibition. We report that blockade of the epidermal growth factor receptor (EGFR) shows strong synergy with BRAF(V600E) inhibition. We find in multiple BRAF(V600E) mutant colon cancers that inhibition of EGFR by the antibody drug cetuximab or the small-molecule drugs gefitinib or erlotinib is strongly synergistic with BRAF(V600E) inhibition, both in vitro and in vivo. Mechanistically, we find that BRAF(V600E) inhibition causes a rapid feedback activation of EGFR, which supports continued proliferation in the presence of BRAF(V600E) inhibition. Melanoma cells express low levels of EGFR and are therefore not subject to this feedback activation. Consistent with this, we find that ectopic expression of EGFR in melanoma cells is sufficient to cause resistance to PLX4032. Our data suggest that BRAF(V600E) mutant colon cancers (approximately 8-10% of all colon cancers), for which there are currently no targeted treatment options available, might benefit from combination therapy consisting of BRAF and EGFR inhibitors. More... »

PAGES

100

Journal

TITLE

Nature

ISSUE

7387

VOLUME

483

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/nature10868

DOI

http://dx.doi.org/10.1038/nature10868

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1038374700

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22281684


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Humanized", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Proliferation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cetuximab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Synergism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme Activation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Erlotinib Hydrochloride", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Feedback, Physiological", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HEK293 Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Indoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Kinase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins B-raf", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quinazolines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA Interference", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor, Epidermal Growth Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sulfonamides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Xenograft Model Antitumor Assays", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Antoni van Leeuwenhoek Hospital", 
          "id": "https://www.grid.ac/institutes/grid.430814.a", 
          "name": [
            "Division of Molecular Carcinogenesis, Center for Biomedical Genetics and Cancer Genomics Centre, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Prahallad", 
        "givenName": "Anirudh", 
        "id": "sg:person.01064364263.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064364263.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Antoni van Leeuwenhoek Hospital", 
          "id": "https://www.grid.ac/institutes/grid.430814.a", 
          "name": [
            "Division of Molecular Carcinogenesis, Center for Biomedical Genetics and Cancer Genomics Centre, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sun", 
        "givenName": "Chong", 
        "id": "sg:person.01200612663.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200612663.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Antoni van Leeuwenhoek Hospital", 
          "id": "https://www.grid.ac/institutes/grid.430814.a", 
          "name": [
            "Division of Molecular Carcinogenesis, Center for Biomedical Genetics and Cancer Genomics Centre, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huang", 
        "givenName": "Sidong", 
        "id": "sg:person.01315041263.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315041263.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "FIRC Institute of Molecular Oncology", 
          "id": "https://www.grid.ac/institutes/grid.7678.e", 
          "name": [
            "Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment, University of Torino, Medical School, Str prov 142 Km 3.95, 10060 Candiolo, Torino, Italy", 
            "FIRC-IFOM Institute for Molecular Oncology, Via Adamello 16, 20100 Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Di Nicolantonio", 
        "givenName": "Federica", 
        "id": "sg:person.0611102073.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611102073.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge", 
          "id": "https://www.grid.ac/institutes/grid.418284.3", 
          "name": [
            "IDIBELL, Institut Catal\u00e0 d\u2019Oncologia L\u2019Hospitalet de Llobregat, Gran Via s/n, km 2, 7 08907 L\u2019Hospitalet-Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Salazar", 
        "givenName": "Ramon", 
        "id": "sg:person.0734346763.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734346763.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Candiolo Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.419555.9", 
          "name": [
            "Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment, University of Torino, Medical School, Str prov 142 Km 3.95, 10060 Candiolo, Torino, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zecchin", 
        "givenName": "Davide", 
        "id": "sg:person.0607031427.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607031427.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Antoni van Leeuwenhoek Hospital", 
          "id": "https://www.grid.ac/institutes/grid.430814.a", 
          "name": [
            "Division of Molecular Carcinogenesis, Center for Biomedical Genetics and Cancer Genomics Centre, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beijersbergen", 
        "givenName": "Roderick L.", 
        "id": "sg:person.01265350126.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265350126.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "FIRC Institute of Molecular Oncology", 
          "id": "https://www.grid.ac/institutes/grid.7678.e", 
          "name": [
            "Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment, University of Torino, Medical School, Str prov 142 Km 3.95, 10060 Candiolo, Torino, Italy", 
            "FIRC-IFOM Institute for Molecular Oncology, Via Adamello 16, 20100 Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bardelli", 
        "givenName": "Alberto", 
        "id": "sg:person.01313502524.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313502524.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Antoni van Leeuwenhoek Hospital", 
          "id": "https://www.grid.ac/institutes/grid.430814.a", 
          "name": [
            "Division of Molecular Carcinogenesis, Center for Biomedical Genetics and Cancer Genomics Centre, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bernards", 
        "givenName": "Ren\u00e9", 
        "id": "sg:person.01366771766.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366771766.51"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1126/science.1075762", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006952665"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m201097200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016285803"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.18.0786", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016398978"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0560.2011.01673.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023289855"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature00766", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023536940", 
          "https://doi.org/10.1038/nature00766"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature00766", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023536940", 
          "https://doi.org/10.1038/nature00766"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0804385", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025462530"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/1040-8428(94)00144-i", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027064147"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.22.4295", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027962078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.14.7116", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031599680"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmc0904160", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033520688"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nchembio774", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035437357", 
          "https://doi.org/10.1038/nchembio774"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nchembio774", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035437357", 
          "https://doi.org/10.1038/nchembio774"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cell.2006.11.053", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040726664"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ccr.2009.02.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041848198"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1103782", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041864150"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.273.22.13703", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043688434"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/path.1511", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043903162"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1014209", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044873328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.23.3452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047799543"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052792626", 
          "https://doi.org/10.1038/nrc1691"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052792626", 
          "https://doi.org/10.1038/nrc1691"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2003-030838", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064287032"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075262313", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-03", 
    "datePublishedReg": "2012-03-01", 
    "description": "Inhibition of the BRAF(V600E) oncoprotein by the small-molecule drug PLX4032 (vemurafenib) is highly effective in the treatment of melanoma. However, colon cancer patients harbouring the same BRAF(V600E) oncogenic lesion have poor prognosis and show only a very limited response to this drug. To investigate the cause of the limited therapeutic effect of PLX4032 in BRAF(V600E) mutant colon tumours, here we performed an RNA-interference-based genetic screen in human cells to search for kinases whose knockdown synergizes with BRAF(V600E) inhibition. We report that blockade of the epidermal growth factor receptor (EGFR) shows strong synergy with BRAF(V600E) inhibition. We find in multiple BRAF(V600E) mutant colon cancers that inhibition of EGFR by the antibody drug cetuximab or the small-molecule drugs gefitinib or erlotinib is strongly synergistic with BRAF(V600E) inhibition, both in vitro and in vivo. Mechanistically, we find that BRAF(V600E) inhibition causes a rapid feedback activation of EGFR, which supports continued proliferation in the presence of BRAF(V600E) inhibition. Melanoma cells express low levels of EGFR and are therefore not subject to this feedback activation. Consistent with this, we find that ectopic expression of EGFR in melanoma cells is sufficient to cause resistance to PLX4032. Our data suggest that BRAF(V600E) mutant colon cancers (approximately 8-10% of all colon cancers), for which there are currently no targeted treatment options available, might benefit from combination therapy consisting of BRAF and EGFR inhibitors.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/nature10868", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.3787869", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1018957", 
        "issn": [
          "0090-0028", 
          "1476-4687"
        ], 
        "name": "Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7387", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "483"
      }
    ], 
    "name": "Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR", 
    "pagination": "100", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b6cd3ca6d68e89013c50b23aab10f3ff5592f7ee0a86fbb888f1b2436ad83ca6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22281684"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0410462"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/nature10868"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1038374700"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/nature10868", 
      "https://app.dimensions.ai/details/publication/pub.1038374700"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:46", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8681_00000434.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/nature10868"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nature10868'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nature10868'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nature10868'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nature10868'


 

This table displays all metadata directly associated to this object as RDF triples.

310 TRIPLES      21 PREDICATES      77 URIs      48 LITERALS      36 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/nature10868 schema:about N0575da1ef2f6435c8df76fad53adbefb
2 N05b5f0b912f44f889c7e4e53a5d1c244
3 N08871d28f3674fb8bccd2393b8f720fa
4 N19398c30d5e14078ade96b2b4ee38362
5 N2c9bbef893a84f6e8875bd4d1fc85c00
6 N2fe439c0a8044e72abe49f2eddf1e74f
7 N30a991438e1b4c89aae02eed20ec60fc
8 N43270c299f22411197ad29dc53d823d3
9 N463dc6aec8804996b964e75b0e7b22ec
10 N522bc499a2e94bb49a934c543b27aca7
11 N66cde9e95d7843bdb9f33e22a5df81ee
12 N6b7e5cd81e584dd6bfd497f44f32fe37
13 N7068a073bb9d491bb41b9c17ab4cc114
14 N89e58518c4cd4bb1b7b6182bb6d72530
15 N9f338fb0c69e4e10b11bab6d4ca8c90b
16 Na421d976e36f483498e7a544e37621ab
17 Na58e1fcf5bed4311842e136245500c31
18 Na9795cad35b5446594a2b3aac2b4fd32
19 Nbadf5ac05eba4169b9c995d6a57b3c28
20 Nccec3cbb123d47e793d9fab86b17f398
21 Ncd9d0bbba51c4d6eb55fe5ee504dfa2f
22 Nd53459ed63c645d7bb26eafe3c6e9b54
23 Nd728698cbb064fdbaca747443cb95ea3
24 Ndd46e4e891264834a9a138b84a192b06
25 Neef5ee74b021451580decdb237f11081
26 Nf9f41173c81b49898b079a5d5f4bc1ca
27 Nff7c22fee6284b75828c79155aad94f5
28 anzsrc-for:11
29 anzsrc-for:1112
30 schema:author N9a6406980d2445f9a50806aee4b7f950
31 schema:citation sg:pub.10.1038/nature00766
32 sg:pub.10.1038/nchembio774
33 sg:pub.10.1038/nrc1691
34 https://app.dimensions.ai/details/publication/pub.1075262313
35 https://doi.org/10.1002/path.1511
36 https://doi.org/10.1016/1040-8428(94)00144-i
37 https://doi.org/10.1016/j.ccr.2009.02.023
38 https://doi.org/10.1016/j.cell.2006.11.053
39 https://doi.org/10.1056/nejmc0904160
40 https://doi.org/10.1056/nejmoa0804385
41 https://doi.org/10.1056/nejmoa1014209
42 https://doi.org/10.1056/nejmoa1103782
43 https://doi.org/10.1074/jbc.273.22.13703
44 https://doi.org/10.1074/jbc.m201097200
45 https://doi.org/10.1111/j.1600-0560.2011.01673.x
46 https://doi.org/10.1126/science.1075762
47 https://doi.org/10.1200/jco.2007.14.7116
48 https://doi.org/10.1200/jco.2008.18.0786
49 https://doi.org/10.1200/jco.2009.22.4295
50 https://doi.org/10.1200/jco.2009.23.3452
51 https://doi.org/10.1210/jc.2003-030838
52 schema:datePublished 2012-03
53 schema:datePublishedReg 2012-03-01
54 schema:description Inhibition of the BRAF(V600E) oncoprotein by the small-molecule drug PLX4032 (vemurafenib) is highly effective in the treatment of melanoma. However, colon cancer patients harbouring the same BRAF(V600E) oncogenic lesion have poor prognosis and show only a very limited response to this drug. To investigate the cause of the limited therapeutic effect of PLX4032 in BRAF(V600E) mutant colon tumours, here we performed an RNA-interference-based genetic screen in human cells to search for kinases whose knockdown synergizes with BRAF(V600E) inhibition. We report that blockade of the epidermal growth factor receptor (EGFR) shows strong synergy with BRAF(V600E) inhibition. We find in multiple BRAF(V600E) mutant colon cancers that inhibition of EGFR by the antibody drug cetuximab or the small-molecule drugs gefitinib or erlotinib is strongly synergistic with BRAF(V600E) inhibition, both in vitro and in vivo. Mechanistically, we find that BRAF(V600E) inhibition causes a rapid feedback activation of EGFR, which supports continued proliferation in the presence of BRAF(V600E) inhibition. Melanoma cells express low levels of EGFR and are therefore not subject to this feedback activation. Consistent with this, we find that ectopic expression of EGFR in melanoma cells is sufficient to cause resistance to PLX4032. Our data suggest that BRAF(V600E) mutant colon cancers (approximately 8-10% of all colon cancers), for which there are currently no targeted treatment options available, might benefit from combination therapy consisting of BRAF and EGFR inhibitors.
55 schema:genre research_article
56 schema:inLanguage en
57 schema:isAccessibleForFree true
58 schema:isPartOf N96f202efc7d349d98e5bc6ad94be04d6
59 Necc12885c20f4a87a273beb149865611
60 sg:journal.1018957
61 schema:name Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
62 schema:pagination 100
63 schema:productId N1b15141508b9439a89691955623ef4a6
64 N5e540034a4894f108988f917e6f23b5a
65 N82737ad05fc84869922727d665b0f2e5
66 Nda0bdc3aba984a8a96204b2404020a73
67 Nf1995499487b4928acd9b80400177f79
68 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038374700
69 https://doi.org/10.1038/nature10868
70 schema:sdDatePublished 2019-04-10T19:46
71 schema:sdLicense https://scigraph.springernature.com/explorer/license/
72 schema:sdPublisher N4553da541e86448888434e0a5fe5d325
73 schema:url https://www.nature.com/articles/nature10868
74 sgo:license sg:explorer/license/
75 sgo:sdDataset articles
76 rdf:type schema:ScholarlyArticle
77 N0575da1ef2f6435c8df76fad53adbefb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Colorectal Neoplasms
79 rdf:type schema:DefinedTerm
80 N05b5f0b912f44f889c7e4e53a5d1c244 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Xenograft Model Antitumor Assays
82 rdf:type schema:DefinedTerm
83 N08871d28f3674fb8bccd2393b8f720fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Humans
85 rdf:type schema:DefinedTerm
86 N19398c30d5e14078ade96b2b4ee38362 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Drug Resistance, Neoplasm
88 rdf:type schema:DefinedTerm
89 N1b15141508b9439a89691955623ef4a6 schema:name nlm_unique_id
90 schema:value 0410462
91 rdf:type schema:PropertyValue
92 N211b732a6ce3456c9c341c20417b1494 rdf:first sg:person.01265350126.64
93 rdf:rest N8a11b9a3147e460997bb0db359b23f35
94 N23331cca236e43b6b7b28d79ec167bd1 rdf:first sg:person.0611102073.45
95 rdf:rest Nad564ea89b9c48d7b8cb76897a13e96d
96 N2c9bbef893a84f6e8875bd4d1fc85c00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Sulfonamides
98 rdf:type schema:DefinedTerm
99 N2fe439c0a8044e72abe49f2eddf1e74f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Protein Kinase Inhibitors
101 rdf:type schema:DefinedTerm
102 N30a991438e1b4c89aae02eed20ec60fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Quinazolines
104 rdf:type schema:DefinedTerm
105 N43270c299f22411197ad29dc53d823d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Cell Line, Tumor
107 rdf:type schema:DefinedTerm
108 N4553da541e86448888434e0a5fe5d325 schema:name Springer Nature - SN SciGraph project
109 rdf:type schema:Organization
110 N463dc6aec8804996b964e75b0e7b22ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name RNA Interference
112 rdf:type schema:DefinedTerm
113 N522bc499a2e94bb49a934c543b27aca7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Apoptosis
115 rdf:type schema:DefinedTerm
116 N5e540034a4894f108988f917e6f23b5a schema:name pubmed_id
117 schema:value 22281684
118 rdf:type schema:PropertyValue
119 N66cde9e95d7843bdb9f33e22a5df81ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Erlotinib Hydrochloride
121 rdf:type schema:DefinedTerm
122 N6b7e5cd81e584dd6bfd497f44f32fe37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Melanoma
124 rdf:type schema:DefinedTerm
125 N7068a073bb9d491bb41b9c17ab4cc114 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Antineoplastic Agents
127 rdf:type schema:DefinedTerm
128 N80c3ca9aa0a4475b8e342fff462cffa8 rdf:first sg:person.01315041263.85
129 rdf:rest N23331cca236e43b6b7b28d79ec167bd1
130 N82737ad05fc84869922727d665b0f2e5 schema:name readcube_id
131 schema:value b6cd3ca6d68e89013c50b23aab10f3ff5592f7ee0a86fbb888f1b2436ad83ca6
132 rdf:type schema:PropertyValue
133 N89e58518c4cd4bb1b7b6182bb6d72530 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Animals
135 rdf:type schema:DefinedTerm
136 N8a11b9a3147e460997bb0db359b23f35 rdf:first sg:person.01313502524.60
137 rdf:rest Ne4916e6a324d444cb21cef10ead00ddc
138 N95b272fa26244de9a18dbf54706d03eb rdf:first sg:person.0607031427.51
139 rdf:rest N211b732a6ce3456c9c341c20417b1494
140 N96f202efc7d349d98e5bc6ad94be04d6 schema:issueNumber 7387
141 rdf:type schema:PublicationIssue
142 N9a6406980d2445f9a50806aee4b7f950 rdf:first sg:person.01064364263.59
143 rdf:rest Nb7cfb86b63a8457c8e511bd09317b213
144 N9f338fb0c69e4e10b11bab6d4ca8c90b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Receptor, Epidermal Growth Factor
146 rdf:type schema:DefinedTerm
147 Na421d976e36f483498e7a544e37621ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Drug Synergism
149 rdf:type schema:DefinedTerm
150 Na58e1fcf5bed4311842e136245500c31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Proto-Oncogene Proteins B-raf
152 rdf:type schema:DefinedTerm
153 Na9795cad35b5446594a2b3aac2b4fd32 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Feedback, Physiological
155 rdf:type schema:DefinedTerm
156 Nad564ea89b9c48d7b8cb76897a13e96d rdf:first sg:person.0734346763.43
157 rdf:rest N95b272fa26244de9a18dbf54706d03eb
158 Nb7cfb86b63a8457c8e511bd09317b213 rdf:first sg:person.01200612663.07
159 rdf:rest N80c3ca9aa0a4475b8e342fff462cffa8
160 Nbadf5ac05eba4169b9c995d6a57b3c28 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Mice
162 rdf:type schema:DefinedTerm
163 Nccec3cbb123d47e793d9fab86b17f398 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name HEK293 Cells
165 rdf:type schema:DefinedTerm
166 Ncd9d0bbba51c4d6eb55fe5ee504dfa2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Cell Proliferation
168 rdf:type schema:DefinedTerm
169 Nd53459ed63c645d7bb26eafe3c6e9b54 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Cetuximab
171 rdf:type schema:DefinedTerm
172 Nd728698cbb064fdbaca747443cb95ea3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Antibodies, Monoclonal
174 rdf:type schema:DefinedTerm
175 Nda0bdc3aba984a8a96204b2404020a73 schema:name doi
176 schema:value 10.1038/nature10868
177 rdf:type schema:PropertyValue
178 Ndd46e4e891264834a9a138b84a192b06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Enzyme Activation
180 rdf:type schema:DefinedTerm
181 Ne4916e6a324d444cb21cef10ead00ddc rdf:first sg:person.01366771766.51
182 rdf:rest rdf:nil
183 Necc12885c20f4a87a273beb149865611 schema:volumeNumber 483
184 rdf:type schema:PublicationVolume
185 Neef5ee74b021451580decdb237f11081 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Female
187 rdf:type schema:DefinedTerm
188 Nf1995499487b4928acd9b80400177f79 schema:name dimensions_id
189 schema:value pub.1038374700
190 rdf:type schema:PropertyValue
191 Nf9f41173c81b49898b079a5d5f4bc1ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Antibodies, Monoclonal, Humanized
193 rdf:type schema:DefinedTerm
194 Nff7c22fee6284b75828c79155aad94f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Indoles
196 rdf:type schema:DefinedTerm
197 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
198 schema:name Medical and Health Sciences
199 rdf:type schema:DefinedTerm
200 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
201 schema:name Oncology and Carcinogenesis
202 rdf:type schema:DefinedTerm
203 sg:grant.3787869 http://pending.schema.org/fundedItem sg:pub.10.1038/nature10868
204 rdf:type schema:MonetaryGrant
205 sg:journal.1018957 schema:issn 0090-0028
206 1476-4687
207 schema:name Nature
208 rdf:type schema:Periodical
209 sg:person.01064364263.59 schema:affiliation https://www.grid.ac/institutes/grid.430814.a
210 schema:familyName Prahallad
211 schema:givenName Anirudh
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064364263.59
213 rdf:type schema:Person
214 sg:person.01200612663.07 schema:affiliation https://www.grid.ac/institutes/grid.430814.a
215 schema:familyName Sun
216 schema:givenName Chong
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200612663.07
218 rdf:type schema:Person
219 sg:person.01265350126.64 schema:affiliation https://www.grid.ac/institutes/grid.430814.a
220 schema:familyName Beijersbergen
221 schema:givenName Roderick L.
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265350126.64
223 rdf:type schema:Person
224 sg:person.01313502524.60 schema:affiliation https://www.grid.ac/institutes/grid.7678.e
225 schema:familyName Bardelli
226 schema:givenName Alberto
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313502524.60
228 rdf:type schema:Person
229 sg:person.01315041263.85 schema:affiliation https://www.grid.ac/institutes/grid.430814.a
230 schema:familyName Huang
231 schema:givenName Sidong
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315041263.85
233 rdf:type schema:Person
234 sg:person.01366771766.51 schema:affiliation https://www.grid.ac/institutes/grid.430814.a
235 schema:familyName Bernards
236 schema:givenName René
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366771766.51
238 rdf:type schema:Person
239 sg:person.0607031427.51 schema:affiliation https://www.grid.ac/institutes/grid.419555.9
240 schema:familyName Zecchin
241 schema:givenName Davide
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607031427.51
243 rdf:type schema:Person
244 sg:person.0611102073.45 schema:affiliation https://www.grid.ac/institutes/grid.7678.e
245 schema:familyName Di Nicolantonio
246 schema:givenName Federica
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611102073.45
248 rdf:type schema:Person
249 sg:person.0734346763.43 schema:affiliation https://www.grid.ac/institutes/grid.418284.3
250 schema:familyName Salazar
251 schema:givenName Ramon
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734346763.43
253 rdf:type schema:Person
254 sg:pub.10.1038/nature00766 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023536940
255 https://doi.org/10.1038/nature00766
256 rdf:type schema:CreativeWork
257 sg:pub.10.1038/nchembio774 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035437357
258 https://doi.org/10.1038/nchembio774
259 rdf:type schema:CreativeWork
260 sg:pub.10.1038/nrc1691 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052792626
261 https://doi.org/10.1038/nrc1691
262 rdf:type schema:CreativeWork
263 https://app.dimensions.ai/details/publication/pub.1075262313 schema:CreativeWork
264 https://doi.org/10.1002/path.1511 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043903162
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1016/1040-8428(94)00144-i schema:sameAs https://app.dimensions.ai/details/publication/pub.1027064147
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1016/j.ccr.2009.02.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041848198
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1016/j.cell.2006.11.053 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040726664
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1056/nejmc0904160 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033520688
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1056/nejmoa0804385 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025462530
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1056/nejmoa1014209 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044873328
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1056/nejmoa1103782 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041864150
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1074/jbc.273.22.13703 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043688434
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1074/jbc.m201097200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016285803
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1111/j.1600-0560.2011.01673.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1023289855
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1126/science.1075762 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006952665
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1200/jco.2007.14.7116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031599680
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1200/jco.2008.18.0786 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016398978
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1200/jco.2009.22.4295 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027962078
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1200/jco.2009.23.3452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047799543
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1210/jc.2003-030838 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064287032
297 rdf:type schema:CreativeWork
298 https://www.grid.ac/institutes/grid.418284.3 schema:alternateName Institut d'Investigació Biomédica de Bellvitge
299 schema:name IDIBELL, Institut Català d’Oncologia L’Hospitalet de Llobregat, Gran Via s/n, km 2, 7 08907 L’Hospitalet-Barcelona, Spain
300 rdf:type schema:Organization
301 https://www.grid.ac/institutes/grid.419555.9 schema:alternateName Candiolo Cancer Institute
302 schema:name Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment, University of Torino, Medical School, Str prov 142 Km 3.95, 10060 Candiolo, Torino, Italy
303 rdf:type schema:Organization
304 https://www.grid.ac/institutes/grid.430814.a schema:alternateName Antoni van Leeuwenhoek Hospital
305 schema:name Division of Molecular Carcinogenesis, Center for Biomedical Genetics and Cancer Genomics Centre, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
306 rdf:type schema:Organization
307 https://www.grid.ac/institutes/grid.7678.e schema:alternateName FIRC Institute of Molecular Oncology
308 schema:name FIRC-IFOM Institute for Molecular Oncology, Via Adamello 16, 20100 Milan, Italy
309 Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment, University of Torino, Medical School, Str prov 142 Km 3.95, 10060 Candiolo, Torino, Italy
310 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...